The guidelines included on this page have been commissioned and endorsed by the BSPED and reflect the Society's views on best practice for the majority of patients with that condition. However, each patient should be considered as an individual in the context of their condition and other medication and therefore the readers' discretion is required in the application of their use. Every effort has been made to ensure the factual accuracy of the contents but no liability can be accepted for any litigation, claims or complaints arising from the use of the guidelines.
If you have a query or comment, or would like to raise a concern regarding a BSPED guideline, or any guideline on this page, please contact the BSPED Office who will ensure your message is passed to the BSPED Clinical Guidelines Officer and Clinical Committee.
These guidelines are produced by accredited national bodies (e.g. NICE, RCPCH, ACDC, SIGN), of which BSPED are stakeholders. BSPED may have been involved in the development of these guidelines but are not the original authors of these guidelines.
Please review the BSPED Clinical Guideline Endorsement document for the process. Authors of guidelines are required to sign the BSPED Declaration of Interest form (definitions of conflicting interests are listed on the form).
�Skip to Paediatric Diabetes Guidelines
Please refer to the ACDC website for Endorsed Guidelines for the most up to date diabetes guidelines listed below.
| Guideline |
Type |
Source |
|
Executive summary - A Practical Approach to the Management of Type 2 Diabetes in children and young people under 18yrs
|
Endorsed |
ACDC/BSPED |
| Care of the Well Child-Newly Diagnosed with Type 1 Diabetes |
Endorsed |
ACDC/BSPED |
| Sick day guideline executive summary v4 |
Endorsed |
ACDC/BSPED |
| Sick day guideline Main V4 |
Endorsed |
ACDC/BSPED |
| Management of Hypoglycaemia in Children and Young People with Type 1 Diabetes |
Endorsed |
ACDC/BSPED |
| A Practical Approach to the Self Management of Diabetes As An Inpatient for Children and Young People Under 18 years |
Endorsed |
ACDC/BSPED |
| A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years |
Endorsed |
ACDC/BSPED |
| A Practical Approach to the Management of Steroid, Chemotherapy or Transplant Induced Hyperglycaemia or Diabetes in Children and Young People Under 18 years in the Acute or Inpatient Setting |
Endorsed |
ACDC/BSPED |
| Dexcom G4 CGM Training Leaflet for Healthcare Professionals and Patients |
Endorsed |
ACDC/BSPED |
| Dexcom G5 CGM Training Leaflet for Healthcare Professionals and Patients |
Endorsed |
ACDC/BSPED |
| Dexcom G6 CGM Training Leaflet for Healthcare Professionals and Patients |
Endorsed |
ACDC/BSPED |
| Medtronic 640G Training Leaflet for Healthcare Professionals and Patients |
Endorsed |
ACDC/BSPED |
| Libre FGS Training Leaflet for Healthcare Professionals and Patients |
Endorsed |
ACDC/BSPED |
| Care of children under 18 years with Diabetes Mellitus undergoing Surgery - currently being updated |
Endorsed |
ACDC/BSPED |
| Executive Summary: A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 years |
Endorsed |
ACDC/BSPED |
| Practical Management of Hyperglycaemic Hyperosmolar State (HHS) in children |
Endorsed |
ACDC/BSPED |
| Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) |
Endorsed |
ACDC/BSPED |
| Executive Summary- Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) |
Endorsed |
ACDC/BSPED |
| Patient Advice for Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) |
Endorsed |
ACDC/BSPED |
*BSPED DKA Guidelines: The Clinical Committee of BSPED are aware that NICE has published its revised guidance on the management of Type 1 and Type 2 Diabetes in Children and Young People(CG 18) We are also aware that this revised NICE guidance differs from the current interim BSPED guidance on the cloud the fluid management of DKA. The Clinical Committee plan to review this situation very quickly but do not feel that the current BSPED DKA guidance need to be removed from the website while this review and revision takes place.
These guidelines are local trust endocrine guidelines which have been made available to BSPED members. The BSPED have not been involved in the development of these guidelines and take no responsibility for the content. Please note local guidelines may vary between Trusts.
If a local trust wishes to publish their guidelines on the BSPED website, please email the BSPED Office (bsped@endocrinology.org) and we will put you in touch with our Clinical Guideline Officer, Dr May Ng.
Chaperone documentation for clinical notes (provided by Birmingham Children's Hospital):
Word version, Excel version, PowerPoint version